Hidradenitis Suppurativa

Toni Jenkins; Jahdonna Isaac; Alicia Edwards; Ginette A Okoye

doi:10.1016/j.det.2023.02.001

Hidradenitis Suppurativa

Dermatol Clin. 2023 Jul;41(3):471-479. doi: 10.1016/j.det.2023.02.001. Epub 2023 Apr 15.

Authors

Toni Jenkins¹, Jahdonna Isaac², Alicia Edwards¹, Ginette A Okoye³

Affiliations

¹ Howard University College of Medicine, 520 West Street NW, Washington, DC 20059, USA.
² Department of Dermatology, Howard University, 2041 Georgia Avenue NW, Towers Suite 4300, Washington, DC 20060, USA.
³ Department of Dermatology, Howard University, 2041 Georgia Avenue NW, Towers Suite 4300, Washington, DC 20060, USA. Electronic address: ginette.okoye@Howard.edu.

PMID: 37236715
DOI: 10.1016/j.det.2023.02.001

Abstract

Hidradenitis suppurativa (HS) is a chronic disease characterized by recurrent painful abscesses and chronic sinus tracts in intertriginous areas. In the United States, HS disproportionally affects adults of African-American heritage. Depending on the severity of disease, the consequences of HS can be far-reaching, significantly affecting mental health and quality of life. In recent years, concerted research efforts have been made to better understand the pathophysiology of the disease as well as identify emerging new treatment targets. Herein, we discuss the clinical presentation, diagnostic criteria, and treatment approach of HS with a focus on skin of color.

Keywords: Acne inversa; Boils; Diagnosis; Health disparities; Hidradenitis suppurativa; Sinus tracts; Skin of color.

Publication types

Review

MeSH terms

Adult
Hidradenitis Suppurativa* / diagnosis
Hidradenitis Suppurativa* / therapy
Humans
Quality of Life
Skin